Cargando…
Author correction to “The FAPα-activated prodrug Z-GP-DAVLBH inhibits the growth and pulmonary metastasis of osteosarcoma cells by suppressing the AXL pathway” [Acta Pharm Sin B 12 (2022) 1288–1304]
Autores principales: | Ye, Geni, Huang, Maohua, Li, Yong, Ouyang, Jie, Chen, Minfeng, Weng, Qing, Li, Xiaobo, Zeng, Huhu, Long, Pei, Fan, Zepei, Yin, Junqiang, Ye, Wencai, Zhang, Dongmei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031275/ https://www.ncbi.nlm.nih.gov/pubmed/36970198 http://dx.doi.org/10.1016/j.apsb.2022.12.020 |
Ejemplares similares
-
The FAPα-activated prodrug Z-GP-DAVLBH inhibits the growth and pulmonary metastasis of osteosarcoma cells by suppressing the AXL pathway
por: Ye, Geni, et al.
Publicado: (2022) -
PharmActa: Empowering Patients to Avoid Clinical Significant Drug–Herb Interactions
por: Spanakis, Marios, et al.
Publicado: (2019) -
Zoledronic acid and thymosin α1 elicit antitumor immunity against prostate cancer by enhancing tumor inflammation and cytotoxic T cells
por: Wang, Sheng, et al.
Publicado: (2023) -
Targeting FAPα-expressing hepatic stellate cells overcomes resistance to antiangiogenics in colorectal cancer liver metastasis models
por: Qi, Ming, et al.
Publicado: (2022) -
Targeting FAPα-expressing hepatic stellate cells overcomes resistance to antiangiogenics in colorectal cancer liver metastasis models
por: Qi, Ming, et al.
Publicado: (2023)